HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Priyanka Bhateja Selected Research

DNA (Deoxyribonucleic Acid)

1/2022Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Priyanka Bhateja Research Topics

Disease

8Neoplasms (Cancer)
12/2024 - 01/2016
8Squamous Cell Carcinoma of Head and Neck
12/2024 - 09/2020
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2024 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2020 - 01/2018
1Neoplasm Metastasis (Metastasis)
04/2024
1Carcinoma (Carcinomatosis)
03/2024
1Osteoradionecrosis
12/2023
1Oropharyngeal Neoplasms
12/2023
1Margins of Excision
09/2020
1Triple Negative Breast Neoplasms
08/2019
1Breast Neoplasms (Breast Cancer)
08/2019
1Basal Cell Carcinoma (Rodent Ulcer)
08/2019
1Glioma (Gliomas)
08/2019
1Retinoblastoma (Glioblastoma, Retinal)
01/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Pathologic Constriction (Stenosis)
01/2016
1Hypercapnia
01/2016
1Laryngeal Neoplasms (Laryngeal Cancer)
01/2016
1Heart Failure
01/2016
1Aspiration Pneumonia
01/2016
1Esophageal Stenosis (Esophageal Stricture)
01/2016
1Deglutition Disorders (Dysphagia)
01/2016
1Respiratory Insufficiency (Respiratory Failure)
01/2016

Drug/Important Bio-Agent (IBA)

4Immune Checkpoint InhibitorsIBA
03/2024 - 02/2020
4Cetuximab (Erbitux)FDA Link
01/2023 - 03/2021
3NivolumabIBA
01/2022 - 03/2021
1RNA (Ribonucleic Acid)IBA
12/2024
1Androgen Receptors (Androgen Receptor)IBA
03/2024
1Circulating Tumor DNAIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1LigandsIBA
01/2022
1cyclopropapyrroloindoleIBA
03/2021
1HhAntag691IBA
08/2019
1GANT 61IBA
08/2019
1sonidegibIBA
08/2019
1Estrogens (Estrogen)FDA Link
08/2019
1Hormones (Hormone)IBA
08/2019
1Transcription Factors (Transcription Factor)IBA
08/2019
1GANT58IBA
08/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Quinacrine (Mepacrine)IBA
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Histone MethyltransferasesIBA
01/2018
1Myeloid-Lymphoid Leukemia ProteinIBA
01/2018
1P-2 (P 2)IBA
01/2016

Therapy/Procedure

5Therapeutics
12/2023 - 02/2020
3Chemoradiotherapy
04/2024 - 01/2016
3Radiotherapy
03/2024 - 12/2016
2Immunotherapy
01/2023 - 01/2022
2Drug Therapy (Chemotherapy)
08/2019 - 01/2019
2Enteral Nutrition (Feeding, Tube)
01/2016 - 01/2016
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2024
1Palliative Care (Palliative Therapy)
03/2021
1Aftercare (After-Treatment)
01/2016
1Gastrostomy
01/2016